The identification of MYBL2, RBM6, VEPH1, AHNAK2, GNG10, and DUSP14 as key genes offers valuable insights into the molecular mechanisms underpinning glioma progression and its interaction with COVID-19. This evidence concerns the gene DUSP14 and central nervous system cancer.